Funding opportunities and RFIs to support research relating to COVID-19 from various agencies/organizations are listed below; please note that this list is not exhaustive. The list will be updated Mondays, Wednesdays, and Fridays by 5 pm. Please contact [email protected] to add a funding opportunity or with any questions.
Proposals for critical continuing laboratory research at Brown that could impact the diagnosis or treatment of COVID-19 in the current crisis should be sent to [email protected] for review and approval.
Invites applications proposing cutting-edge research on emerging viral infections that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract. Investigate possible effects of emerging viruses on reproductive tissues and cells to better understand potential impacts on fertility that may be sex specific. Apply via PA-20-185 or PA-18-482.
Supports groundbreaking research related to COVID-19 infected lung cancer patients by junior faculty researchers, namely research in epidemiology, pathology, imaging, immuno-biology and immune biomarkers, and translational science in COVID-19 positive lung cancer patients.
Encourages cooperative agreement applications for implementation of investigator-initiated high-risk clinical trials that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2 to evaluate: SARS-CoV-2 candidate vaccines; non-vaccine biomedical prevention of SARS-CoV-2 infection and/or COVID-19; therapeutic approaches to treat COVID-19. Apply via PAR-18-633.
This RFI invites information to understand the current surveillance testing capabilities at universities, and the potential for university-based networks to jointly deploy existing equipment and staff to develop robust SARS-CoV-2 surveillance testing for their students, faculty and staff, and possibly for other critical institutions in their local communities
Invites proposals for research projects focused on Health Promotion; special attention will be given to the projects which incorporate aspects related to COVID-19 such as: reducing infections, self-care and the culture of self-protection, relationship between previous health status (lifestyle) and morbimortality, COVID-19 and mental health, etc.
Biomedical, Clinical Research, Social Sciences, Public Health
This addition to NOT-OD-20-048 seeks to fund investigations of the risk factors associated with COVID-19 disease prevalence among NIH-designated health disparity populations and various categories of women; intersectional and community-based research; and research to assess social and behavioral processes that affect SARS-CoV-2 infection vulnerability and disease severity in underrepresented, understudied, and underreported (U3) populations. Apply via PA-18-591.
This initiative aims to support further development, commercialization, and implementation of technologies for chemosensory testing to screen patients for COVID-19 and to complement current temperature screening procedures. Apply via PA-20-135.
This FOA seeks to support innovative research to develop novel, new or unique and non-traditional approaches (e.g. diagnostic and prognostic biomarkers and/or biosignatures) to identify and characterize the spectrum of SARS CoV-2 associated illness, including the multisystem inflammatory syndrome in children (MIS-C) and, through a prognostic algorithm, predict the longitudinal risk of disease severity after a child is exposed to and may be infected with SARS-CoV-2 to properly tailor his or her management and optimize health outcomes
This RFA will support the early stage development of an innovative platform that integrates biosensing with touchscreen or other digital devices to achieve detection and tracing of SARS-CoV-2 in real-time. Projects are expected to demonstrate proof-of-concept of SARS-CoV-2 detection with high sensitivity and specificity, sensor functionality, and automatic detection by touchscreen or other digital devices
This FOA seeks to use developed technologies for single vesicle or exosome isolation and analysis and reposition these technologies for the detection of SARS-CoV-2. NOTE: Brown can only submit ONE application for this opportunity; please see the internal selection page if interested.
This FOA is seeking applications for a portable sensing device to detect volatile organic compounds (VOCs, i.e., scents or odors) emanating from skin or exhaled breath, saliva and different oral tissues from the oral cavity. These sensing devices must be able to associate VOC patterns to patients with symptomatic and asymptomatic COVID-19. This FOA seeks to advance novel biosensing technologies that are innovative, safe, and effective using integrated artificial intelligent, pattern recognition and machine learning systems that would make it possible for the detection, diagnosis, prediction, and monitoring of COVID-19 in clinical, community and everyday settings. NOTE: Brown can only submit ONE application for this opportunity; please see the internal selection page if interested.
This FOA invites applications to pursue development and validation studies of COVID-19 surveillance methods, not based or focused on direct viral testing of individuals, in settings and institutions, including residential, with a high density of individuals who are together for prolonged periods of time. Applications are invited that translate a combination of digital surveillance modalities into platforms that can assist the professional staff of high-risk facilities in making clinically meaningful care recommendations for patients at risk of COVID-19 or other respiratory viruses. Projects proposed may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate.
The goal of this FOA is to solicit applications to enhance the utility of chemosensory testing as a COVID-19 screening tool by using objective tests to examine the onset and prognostic value of chemosensory loss and to encourage the development and/or deployment of home-based and on-site chemosensory tests
Invites applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections
This FOA will support wastewater-based testing (WBT) surveillance which can provide detailed mapping of the extent and spread of COVID-19 via cooperative agreements both for field studies and for small business research and development projects in the field of WBT, to address topics such as: investigation and demonstration of specific approaches aiming to increase sensitivity and to inform and optimize sample collection; implementation and development of optimized approaches to extrapolate estimation of population-level data within the community; development of optimized intervention strategies, and incorporation of computational, statistical, and mathematical models
American Psychological Foundation will support psychological research that will provide insights that will help psychologists to work with individuals, families and groups who are struggling to cope during these challenging times, including: use of telemedicine as a form of psychological intervention; loneliness and isolation due to social distancing and remote work; examining the impact of the COVID-19 pandemic on families and children (i.e., association between financial strain and domestic abuse; the effect of exposure of children to caretaker substance abuse during social isolation); literature review of existing research to identify best practices
Supports basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK
NIAID is allowing the submission of applications for Competitive Revisions to active grants to increase and enhance select research efforts to facilitate the Federal SARS-CoV-2/COVID-19 research response. Areas of interest are limited to: Support to BSL3 facilities actively engaged in the SARS-CoV-2/COVID-19 research response; Generation of critical reagents to support the SARS-CoV-2/COVID-19 research response; Expansion of relevant data systems to expeditiously share SARS-CoV-2/COVID-19 research resources with the broad research community; Expansion of clinical trial infrastructure, or site preparation, for urgent SARS-CoV-2/COVID-19 clinical trial activities. See the NOSI for details; apply via PA-20-135
Focuses on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations
Invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19)
Biomedical, Clinical Research, Social Sciences, Public Health
Encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups
Research is needed to test community interventions focused on the prevention (or slowing) of COVID-19 transmission, evaluate local and state policies and programs intended to mitigate COVID-19 exposure and improve adherence, and reduce the negative impact of the multifaceted consequences on the health of populations who experience health disparities and other vulnerable groups. Apply via PA-18-935 or PA-18-591.
The purpose of this NOSI is to support research to address secondary health effects of the social, behavioral, and economic changes, particularly among populations who experience health disparities and vulnerable populations through the use of digital health assessments and interventions to yield measurable near-term impact. Apply via PA-18-935 or PA-18-591.
Transformative Research Awards from CARES Act funding that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics
Biomedical, Clinical Research, Technology development
Supports studies to understand critical aspects of SARS-CoV-2 viral infection, replication, pathogenesis, transmission, and immune response; development of rapid clinical diagnostic tests, therapeutic candidates, and vaccine candiadtes for SARS-CoV-2
NCI anticipates that in infrequent cases, NCI-funded investigators will have novel insights and research proposals of immediate relevance to SARS-CoV-2 and COVID-19. In those cases, but only for the duration of the present crisis, NCI would consider requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources.
NIDCR will fund Urgent Competitive Revisions and Administrative Supplements that would be of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices. These topics include prevention of SARS-COV-2 transmission and improvements in the detection and diagnosis of COVID-19; as well as acquisition of a more robust understanding of SARS-CoV-2 pathogenesis. Apply via PA-18-591 or PA-18-935.
Remote Access, in-kind Lab labor; not a monetary grant
Biomedical, Clinical Research
Oak Ridge National Laboratory (ORNL) is currently restricting site access. Rapid Access proposals will be performed as remote access experiments with limited internal staff. The Department of Energy Basic Energy Sciences advanced neutron sources will provide remote rapid access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapies. Facilities that will be made available at the Spallation Neutron Source (SNS) and High Flux Isotope Reactor (HFIR) at ORNL , include neutron macromolecular crystallography, small-angle scattering, reflectometry, spectroscopy and imaging beamlines.
Technology development, Biomedical, Computation, Engineering, Physical Sciences, Social Sciences, Public Health, Humanities
The Mercatus Center at George Mason University, building on its COVID-19 policy brief series, welcomes proposals for policy briefs, working papers, and articles that address the next round of challenges facing the United States and other countries in the response to the pandemic.
Urgent competitive revisions and administrative supplements to existing grants to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes. Apply via PA-18-935 or PA-18-591.
Development, translation, and commercialization of technologies to address COVID-19; develop life-saving technologies that can be ready for commercialization within one to two years. Apply via PA-20-135 or PA-18-591.
Research on stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections. Apply via PA-18-591 or PA-18-935.
Strengthen the mental health response to COVID-19 and to future public health emergencies; research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention. Apply via PA-18-935 or PA-18-591.
Impact of the novel Coronavirus pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations. Apply via PA-18-935 or PA-18-591.
Impact of environmental exposures on COVID-19; the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies. Apply via PA-20-135.
Innovative technologies that propose new solutions and/or potentially new capabilities in support of the COVID-19 Response Acquisition Task Force (DAF ACT) mission to provide relief, resilience, recovery, and stability to the nation in response to the COVID-19 pandemic
NIA & NIMH are offering Supplements & Revisions to certain active grants. NIA: improve prevention of disease transmission among older adults and mitigation of disease severity and mortality in older adults with COVID-19. NIMH: examine how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or worsening mental health needs and/or suicide risk in midlife and older age adults. Apply via PA-18-935 or PA-18-591.
Google is offering Google Cloud credits for researchers to leverage their computing capabilities and infrastructure as they study potential therapies and vaccines, track critical data, and identify new ways to combat COVID-19
Biomedical, Clinical Research, Technology development
The U.S. government is providing a portal for the 2019 novel coronavirus (COVID-19) medical countermeasures task force as a single point of entry for the submission of ideas and information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak.
The DARPA technical offices that are focused on COVID-19 efforts are the Defense Sciences Office (DSO) and the Biological Technology Office (BTO), both of which have Office-Wide Broad Agency Announcements (BAA) that are open for the submission of new ideas at any time.